Suppr超能文献

典型心绞痛且运动试验阳性女性中阻塞性冠状动脉疾病与心脏X综合征的鉴别;心血管风险计算器的效用

Discrimination between Obstructive Coronary Artery Disease and Cardiac Syndrome X in Women with Typical Angina and Positive Exercise Test; Utility of Cardiovascular Risk Calculators.

作者信息

Saadat Mohammad, Masoudkabir Farzad, Afarideh Mohsen, Ghodsi Saeed, Vasheghani-Farahani Ali

机构信息

Cardiac Primary Prevention Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran 1411713138, Iran.

Department of Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran 1411713138, Iran.

出版信息

Medicina (Kaunas). 2019 Jan 14;55(1):12. doi: 10.3390/medicina55010012.

Abstract

Nearly 40% of women with typical angina and a positive exercise tolerance test (ETT) have normal or near normal coronary angiography (CAG) labeled as cardiac syndrome X (CSX). We performed this study to evaluate the power of common cardiovascular risk calculators to distinguish patients with CSX from those with coronary artery disease (CAD). 559 women participated in the study. Three risk scores, including (1) newly pooled cohort equation of American College of Cardiology/American Heart Association (ACC/AHA) to predict 10 years risk of first atherosclerotic cardiovascular hard event (ASCVD), (2) Framingham risk score (FRS) for the prediction of 10 years coronary heart disease, and (3) the SCORE tool to estimate 10-year risk of cardiovascular mortality (SCORE), were applied. CAD was diagnosed in 51.5% of the patients. 11.6% of the population had ASCVD < 2.5%, and only 13.8% of these patients had CAD on their CAG. By choosing FRS, 14.4% of patients had FRS < 7.5%, and only 11.3% of these patients had recorded CAD on CAG, while the rest of the patients were diagnosed as CSX. Using the SCORE model, 13.8% of patients had the least value (<0.5%) in whom the prevalence of CAD was 19.9%. The area under receiver operating characteristic curve (AUROC) to discriminate CSX from CAD was calculated for each scoring system, being 0.750 for ASCVD, 0.745 for FRS, and 0.728 for SCORE ( value for all AUROCs < 0.001). The Hosmer⁻Lemeshow chi squares (df, value) for calibration were 8.787 (8, 0.361), 11.125 (8, 0.195), and 10.618 (8, 0.224) for ASCVD, FRS, and SCORE, respectively. Patients who have ASCVD < 2.5% or FRS < 7.5% may be appropriate cases for noninvasive imaging (Such as coronary CT angiography). CAG is indicated for patients with ASCVD ≥ 7.5% and FRS ≥ 15%, whereas the patients with intermediate risk need comprehensive patient⁻physician shared decision-making.

摘要

近40%有典型心绞痛且运动耐量试验(ETT)呈阳性的女性冠状动脉造影(CAG)结果正常或接近正常,被标记为心脏综合征X(CSX)。我们开展这项研究以评估常用心血管风险计算器区分CSX患者与冠状动脉疾病(CAD)患者的能力。559名女性参与了该研究。应用了三种风险评分,包括:(1)美国心脏病学会/美国心脏协会(ACC/AHA)新汇总队列方程,用于预测首次动脉粥样硬化性心血管硬事件(ASCVD)的10年风险;(2)弗雷明汉风险评分(FRS),用于预测10年冠心病风险;(3)SCORE工具,用于评估心血管死亡的10年风险(SCORE)。51.5%的患者被诊断为CAD。11.6%的人群ASCVD<2.5%,这些患者中仅13.8%在CAG检查中有CAD。选择FRS时,14.4%的患者FRS<7.5%,这些患者中仅11.3%在CAG检查中有CAD记录,其余患者被诊断为CSX。使用SCORE模型时,13.8%的患者风险值最低(<0.5%),其中CAD患病率为19.9%。计算了每个评分系统用于区分CSX与CAD的受试者工作特征曲线下面积(AUROC),ASCVD为0.750,FRS为0.745,SCORE为0.728(所有AUROC的P值<0.001)。校准的Hosmer-Lemeshow卡方值(自由度,P值),ASCVD为8.787(8,0.361),FRS为11.125(8,0.195),SCORE为10.618(8,0.224)。ASCVD<2.5%或FRS<7.5%的患者可能适合进行无创成像检查(如冠状动脉CT血管造影)。对于ASCVD≥7.5%且FRS≥15%的患者,建议进行CAG检查,而中度风险的患者需要患者与医生共同进行全面的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/376a/6359077/3608a7bd85fd/medicina-55-00012-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验